Symptoms


Select item(s)
Key Findings
Diarrhea and Abdominal pain were the only gastrointestinal symptoms with 5.9% prevalence each, out of 187 symptomatic cases.
PMID 33513332
Title Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands
Author(s) nameKristiansen MF, Heimustovu BH, Borg SÁ, Mohr TH, Gislason H, Møller LF, Christiansen DH, Steig BÁ, Petersen MS, Strøm M, Gaini S.
Journal Emerg Infect Dis
Impact factor6.81
Citation count1
Date of publishing2021 Mar
Cough (44.4%) was one of the prevalent respiratory symptom among 166 symptomatic cases, followed by sore throat (30%).
PMID 33513332
Title Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands
Author(s) nameKristiansen MF, Heimustovu BH, Borg SÁ, Mohr TH, Gislason H, Møller LF, Christiansen DH, Steig BÁ, Petersen MS, Strøm M, Gaini S.
Journal Emerg Infect Dis
Impact factor6.81
Citation count1
Date of publishing2021 Mar
88.8% were symptomatic, of which Fever (63%) and Headache (47.6%) were the major symptoms in general whereas only 11.2% were asymptomatic.
PMID 33513332
Title Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands
Author(s) nameKristiansen MF, Heimustovu BH, Borg SÁ, Mohr TH, Gislason H, Møller LF, Christiansen DH, Steig BÁ, Petersen MS, Strøm M, Gaini S.
Journal Emerg Infect Dis
Impact factor6.81
Citation count1
Date of publishing2021 Mar
This research had focused on evaluating the presence of symptoms of Anxiety Disorder in adolescents with hearing loss during the COVID-19 pandemic.
PMID 33618708
Title Symptoms of anxiety disorders in Iranian adolescents with hearing loss during the COVID-19 pandemic
Author(s) nameAriapooran S, Khezeli M.
Journal BMC Psychiatry
Impact factor2.86
Citation count1
Date of publishing2021 Feb 22
100 Patients were surveyed post-discharge and the symptoms reported by them were recorded and divided into two categories based on whether or not they were in the ICU during hospitalisation.
PMID 32729939
Title Postdischarge symptoms and rehabilitation needs in survivors of COVID19 infection: A crosssectional evaluation
Author(s) nameHalpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O'Connor RJ, Sivan M.
Journal J Med Virol
Impact factor2.07
Citation count12
Date of publishing2021 Feb
A cross sectional study including 105 patients with documented clinical recovery and virological clearance to evaluate the prevalence of anxiety or/and depression.
PMID 32841387
Title Anxiety and depression symptoms after virological clearance of COVID19: a crosssectional study in Milan, Italy
Author(s) nameTomasoni D, Bai F, Castoldi R, Barbanotti D, Falcinella C, Mulè G, Mondatore D, Tavelli A, Vegni E, Marchetti G, d'Arminio Monforte A.
Journal J Med Virol
Impact factor2.07
Citation count2
Date of publishing2021 Feb
All the 3 clusters share Headache, Myalgia, Sore throat as common symptoms based on Tandem clustering analysis. 87,253 (56%) belonged to the common cluster and was reported the most frequent cluster. Symptomatic cases (20%) were more in contact with COVID-19 cases than presymptomatic (9%).
PMID 33434668
Title Epidemiology of COVID-19 in Mexico: Symptomatic profiles andpresymptomatic people
Author(s) nameFernández-Rojas MA, Luna-Ruiz Esparza MA, Campos-Romero A, Calva-Espinosa DY, Moreno-Camacho JL, Langle-Martínez AP, García-Gil A, Solís-González CJ, Canizalez-Román A, León-Sicairos N, Alcántar-Fernández J.
Journal Int J Infect Dis
Impact factor3.42
Citation count1
Date of publishing2021 Jan 9
Respiratory symptoms cluster was the second most frequent cluster with 34% occurence rate (52,827). Family members with COVID-19 were more frequently symptomatic (13%) than presymptomatic (6%).
PMID 33434668
Title Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people
Author(s) nameFernández-Rojas MA, Luna-Ruiz Esparza MA, Campos-Romero A, Calva-Espinosa DY, Moreno-Camacho JL, Langle-Martínez AP, García-Gil A, Solís-González CJ, Canizalez-Román A, León-Sicairos N, Alcántar-Fernández J.
Journal Int J Infect Dis
Impact factor3.42
Citation count1
Date of publishing2021 Jan 9
Gastrointestinal symptoms cluster was the third frequent cluster with 10% occurrence rate (16,518). Non-communicable diseases (Hypertension, Diabetes, Obesity) were more prevalent in symptomatic than presymptomatic cases.
PMID 33434668
Title Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people
Author(s) nameFernández-Rojas MA, Luna-Ruiz Esparza MA, Campos-Romero A, Calva-Espinosa DY, Moreno-Camacho JL, Langle-Martínez AP, García-Gil A, Solís-González CJ, Canizalez-Román A, León-Sicairos N, Alcántar-Fernández J.
Journal Int J Infect Dis
Impact factor3.42
Citation count1
Date of publishing2021 Jan 9
Fever was the major symptom in 25 patients among 36 symptomatic cases, whereas Chest pain, Headache, Fatigue, Myalgia and Delirium were all minor symptoms.
PMID 33509318
Title Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020
Author(s) namePett J, McAleavey P, McGurnaghan P, Spiers R, O'Doherty M, Patterson L, Johnston J.
Journal Epidemiol Infect
Impact factor2.01
Citation count1
Date of publishing2021 Jan 29
Cough was the most prevalent respiratory symptom and was reported in 24 of 36 symptomatic patients.
PMID 33509318
Title Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020
Author(s) namePett J, McAleavey P, McGurnaghan P, Spiers R, O'Doherty M, Patterson L, Johnston J.
Journal Epidemiol Infect
Impact factor2.01
Citation count1
Date of publishing2021 Jan 29
A case study in Mexico, of a SARS-CoV-2 positive patient presenting hiccups as the only symptom.
PMID 33472577
Title Hiccups and psychosis: two atypical presentations of COVID-19
Author(s) nameAlvarez-Cisneros T, Lara-Reyes A, Sansón-Tinoco S.
Journal Int J Emerg Med
Impact factor
Citation count1
Date of publishing2021 Jan 20
A case study in Mexico, of a SARS-CoV-2 positive patient with an acute episode of pychosis as the only symptom.
PMID 33472577
Title Hiccups and psychosis: two atypical presentations of COVID-19
Author(s) nameAlvarez-Cisneros T, Lara-Reyes A, Sansón-Tinoco S.
Journal Int J Emerg Med
Impact factor
Citation count1
Date of publishing2021 Jan 20
This study characterises the prevalence, onset and nature of musculoskeletal complaints in COVID-19 patients and explores their clinical significance.
PMID 33476761
Title Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms
Author(s) nameHoong CWS, Amin MNME, Tan TC, Lee JE.
Journal Int J Infect Dis
Impact factor3.42
Citation count1
Date of publishing2021 Jan 18
The study was conducted in a virtual outpatient COVID-19 clinic with aims to describe symptom profile and clinical outcomes.
PMID 33469566
Title Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting
Author(s) nameKnight D, Downes K, Munipalli B, Halkar MG, Logvinov II, Speicher LL, Hines SL.
Journal SN Compr Clin Med
Impact factorCant find
Citation count1
Date of publishing2021 Jan 14
103 COVID-19 patients were screened for 13 subjective neurological symptoms along with anxiety and depression as a major focus.
PMID 32987349
Title Depressive and anxiety symptoms in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, Ora J, Mina GG, Puxeddu E, Balbi O, Pezzuto G, Magrini A, Rogliani P, Andreoni M, Mercuri NB.
Journal J Affect Disord
Impact factor4.17
Citation count1
Date of publishing2021 Jan 1
103 COVID-19 patients were screened for 13 subjective neurological symptoms along with anxiety and depression as a major focus.
PMID 32987349
Title Depressive and anxiety symptoms in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, Ora J, Mina GG, Puxeddu E, Balbi O, Pezzuto G, Magrini A, Rogliani P, Andreoni M, Mercuri NB.
Journal J Affect Disord
Impact factor4.17
Citation count1
Date of publishing2021 Jan 1
A study among clinical healthcare workers to determine rates of anxiety and depression and the factors associated with their prevalence.
PMID 32961409
Title Anxiety and depression symptoms of medical staff under COVID-19 epidemic in China
Author(s) nameLiu Y, Chen H, Zhang N, Wang X, Fan Q, Zhang Y, Huang L, Hu B, Li M.
Journal J Affect Disord
Impact factor4.17
Citation count4
Date of publishing2021 Jan 1
A multinational cross-sectiolnal survey to determine prevelance of anxiety symptoms and associated risk and protective factors during the COVID-19 pandemic.
PMID 33035760
Title Frequency and correlates of anxiety symptoms during the COVID-19 pandemic in low- and middle-income countries: A multinational study
Author(s) nameCénat JM, Dalexis RD, Guerrier M, Noorishad PG, Derivois D, Bukaka J, Birangui JP, Adansikou K, Clorméus LA, Kokou-Kpolou CK, Ndengeyingoma A, Sezibera V, Auguste RE, Rousseau C.
Journal J Psychiatr Res
Impact factor4.23
Citation count3
Date of publishing2021 Jan
A study of patients discharged from a single centre in France,conducted to monitor the persistence of symptoms post-discharge, through a telephonic questionnaire.
PMID 32853602
Title Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
Author(s) nameGarrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y.
Journal J Infect
Impact factor5.1
Citation count12
Date of publishing2020 Dec
A case study of a 52 year old man with SARS-CoV-2 infection who developed vesicular skin eruptions and subsequent GI symptons but not any typical symptoms associated with COVID-19.
PMID 33471878
Title Skin eruption and gastrointestinal symptoms as presentation of COVID-19
Author(s) nameChu S, Christensen LF, Vidmar D.
Journal Cutis
Impact factor0.47
Citation count1
Date of publishing2020 Dec
Analysis of 11 COVID-19 positive patients with recurrent viral symptoms or viral re-infection.
PMID 32619697
Title Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?
Author(s) nameGousseff M, Penot P, Gallay L, Batisse D, Benech N, Bouiller K, Collarino R, Conrad A, Slama D, Joseph C, Lemaignen A, Lescure FX, Levy B, Mahevas M, Pozzetto B, Vignier N, Wyplosz B, Salmon D, Goehringer F, Botelho-Nevers E; in behalf of the COCOREC study group.
Journal J Infect
Impact factor5.1
Citation count43
Date of publishing2020 Nov
34.3% of liver transplant recipients with COVID-19 presented Dyspnea as a respiratory symptom.
PMID 32891405
Title Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis
Author(s) nameFraser J, Mousley J, Testro A, Smibert OC, Koshy AN.
Journal Transplant Proc
Impact factor0.95
Citation count4
Date of publishing2020 Nov
2701 volunteers were surveyed to assess perceived stress, sleep quality, insomnia, depression symptoms, and anxiety, using standard questionnaires.
PMID 33102641
Title Gender-related time course of sleep disturbances and psychological symptoms during the COVID-19 lockdown: a longitudinal study on the Italian population
Author(s) nameSalfi F, Lauriola M, Amicucci G, Corigliano D, Viselli L, Tempesta D, Ferrara M.
Journal Neurobiol Stress
Impact factor
Citation count1
Date of publishing2020 Nov
67% of liver transplant recipients with COVID-19 presented Fever as a general symptom.
PMID 32891405
Title Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis
Author(s) nameFraser J, Mousley J, Testro A, Smibert OC, Koshy AN.
Journal Transplant Proc
Impact factor0.95
Citation count4
Date of publishing2020 Nov